Virtual Oncology

May
15

Real-World Evidence: Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer

Participate in this free CME Snack to hear Dr. Martine Piccart discuss randomized, controlled trials, real-world data, and real-world evidence, focusing on the current real-world evidence in the field of cylcin-dependent kinase (CDK) 4/6 inhibitors in metastatic breast cancer. Earn CME/CE credit in just 20 minutes!

Read More
DETAIL
May
14

Case Challenge: Incorporate Real-World Evidence in the Management of Hormone Receptor-Positive Metastatic Breast Cancer

In this CME Outfitters BriefCase webcast, expert faculty discuss the challenges and nuances of a case scenario as well as practical strategies for incorporating RWE into daily clinical practice in MBC.

Read More
DETAIL